Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases

Por Schicho, Rudolf, Storr, Martin
Publicado em 2011

Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice

Por Schicho, Rudolf, Storr, Martin
Publicado em 2012

A potential role for GPR55 in gastrointestinal functions

Por Schicho, Rudolf, Storr, Martin
Publicado em 2012

IBD patients find symptom relief in the Cannabis field

Por Schicho, Rudolf, Storr, Martin
Publicado em 2013

Cannabis finds its way into treatment of Crohn’s disease

Por Schicho, Rudolf, Storr, Martin
Publicado em 2013

Cardiovascular complications in inflammatory bowel disease

Por Schicho, Rudolf, Marsche, Gunther, Storr, Martin
Publicado no Curr Drug Targets (2015)

Potential causes and present pharmacotherapy of irritable bowel syndrome (IBS): an overview

Por Bokic, Theodor, Storr, Martin, Schicho, Rudolf
Publicado no Pharmacology (2015)

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

Por Hasenoehrl, Carina, Storr, Martin, Schicho, Rudolf
Publicado no Expert Rev Gastroenterol Hepatol (2017)

Metabolomics: is it useful for IBD?

Por Storr, Martin, Vogel, Hans J., Schicho, Rudolf
Publicado em 2013

Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review

Por Sarosiek, Irene, Schicho, Rudolf, Blandon, Pedro, Bashashati, Mohammad
Publicado no World J Gastrointest Oncol (2016)

The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease

Por Hasenoehrl, Carina, Taschler, Ulrike, Storr, Martin, Schicho, Rudolf
Publicado no Neurogastroenterol Motil (2016)

The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model

Por Kargl, Julia, Haybäck, Johannes, Stančić, Angela A, Marsche, Gunther, Heinemann, Ákos, Schicho, Rudolf
Publicado em 2012

O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms

Por Kargl, Julia, Haybaeck, Johannes, Stanc̆ić, Angela, Andersen, Liisa, Marsche, Gunther, Heinemann, Akos, Schicho, Rudolf
Publicado em 2012

Neutrophil effector responses are suppressed by secretory phospholipase A(2) modified HDL

Por Curcic, Sanja, Holzer, Michael, Frei, Robert, Pasterk, Lisa, Schicho, Rudolf, Heinemann, Akos, Marsche, Gunther
Publicado no Biochim Biophys Acta (2014)

The GPR55 antagonist CID16020046 protects against intestinal inflammation

Por Stančić, Angela, Jandl, Katharina, Hasenöhrl, Carina, Reichmann, Florian, Marsche, Gunther, Schuligoi, Rufina, Heinemann, Akos, Storr, Martin, Schicho, Rudolf
Publicado no Neurogastroenterol Motil (2015)

The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors: “MPO generates irreversible SR-BI inhibitors”

Por Binder, Veronika, Ljubojevic, Senka, Haybaeck, Johannes, Holzer, Michael, El-Gamal, Dalia, Schicho, Rudolf, Pieske, Burkert, Heinemann, Akos, Marsche, Gunther
Publicado em 2013

Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by (1)H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals

Por Schicho, Rudolf, Shaykhutdinov, Rustem, Ngo, Jennifer, Nazyrova, Alsu, Schneider, Christopher, Panaccione, Remo, Kaplan, Gilaad G., Vogel, Hans J., Storr, Martin
Publicado em 2012

Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression

Por Pasterk, Lisa, Lemesch, Sandra, Leber, Bettina, Trieb, Markus, Curcic, Sanja, Stadlbauer, Vanessa, Schuligoi, Rufina, Schicho, Rudolf, Heinemann, Akos, Marsche, Gunther
Publicado no Sci Rep (2016)

Cyanate Is a Novel Inducer of Endothelial ICAM-1 Expression

Por El-Gamal, Dalia, Holzer, Michael, Gauster, Martin, Schicho, Rudolf, Binder, Veronika, Konya, Viktoria, Wadsack, Christian, Schuligoi, Rufina, Heinemann, Akos, Marsche, Gunther
Publicado em 2012

A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice

Por Li, Kun, Fichna, Jakub, Schicho, Rudolf, Saur, Dieter, Bashashati, Mohammad, Mackie, Ken, Li, Yongyu, Zimmer, Andreas, Göke, Burkhard, Sharkey, Keith A., Storr, Martin
Publicado em 2013